RT Journal Article
T1 Executive summary: Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.
A1 Iribarren, José Antonio
A1 Rubio, Rafael
A1 Aguirrebengoa, Koldo
A1 Arribas, Jose Ramón
A1 Baraia-Etxaburu, Josu
A1 Gutiérrez, Félix
A1 Lopez Bernaldo de Quirós, Juan Carlos
A1 Losa, Juan Emilio
A1 Miró, José Ma
A1 Moreno, Santiago
A1 Pérez Molina, José
A1 Podzamczer, Daniel
A1 Pulido, Federico
A1 Riera, Melchor
A1 Rivero, Antonio
A1 Sanz Moreno, José
A1 Amador, Concha
A1 Antela, Antonio
A1 Arazo, Piedad
A1 Arrizabalaga, Julio
A1 Bachiller, Pablo
A1 Barros, Carlos
A1 Berenguer, Juan
A1 Caylá, Joan
A1 Domingo, Pere
A1 Estrada, Vicente
A1 Knobel, Hernando
A1 Locutura, Jaime
A1 López Aldeguer, José
A1 Llibre, Josep Ma
A1 Lozano, Fernando
A1 Mallolas, Josep
A1 Malmierca, Eduardo
A1 Miralles, Celia
A1 Miralles, Pilar
A1 Muñoz, Agustín
A1 Ocampo, Agustín
A1 Olalla, Julián
A1 Pérez, Inés
A1 Pérez Elías, Ma Jesús
A1 Pérez Arellano, José Luis
A1 Portilla, Joaquín
A1 Ribera, Esteban
A1 Rodríguez, Francisco
A1 Santín, Miguel
A1 Sanz Sanz, Jesús
A1 Téllez, Ma Jesús
A1 Torralba, Miguel
A1 Valencia, Eulalia
A1 Von Wichmann, Miguel Angel
A1 GESIDA/SEIMC Writing Committee, 
K1 AIDS
K1 HIV infection
K1 Infecciones oportunistas
K1 Infección por VIH
K1 Opportunistic infections
K1 Sida
AB Opportunistic infections continue to be a cause of morbidity and mortality in HIV-infected patients. They often arise because of severe immunosuppression resulting from poor adherence to antiretroviral therapy, failure of antiretroviral therapy, or unawareness of HIV infection by patients whose first clinical manifestation of AIDS is an opportunistic infection. The present article is an executive summary of the document that updates the previous recommendations on the prevention and treatment of opportunistic infections in HIV-infected patients, namely, infections by parasites, fungi, viruses, mycobacteria, and bacteria, as well as imported infections. The article also addresses immune reconstitution inflammatory syndrome. This document is intended for all professionals who work in clinical practice in the field of HIV infection.
YR 2016
FD 2016-04-05
LK https://hdl.handle.net/10668/24870
UL https://hdl.handle.net/10668/24870
LA en
DS RISalud
RD Apr 17, 2025